Drug
14c Etrumadenant
14c Etrumadenant: highest development phase Phase 1, developed by Arcus Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]-etrumadenant NCT05411146 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow 14c Etrumadenant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.